A Phase Ib, Multi-center, Two Parallel Group, Open-label, Drug-drug Interaction Study to Assess the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 19 Aug 2016
Price : $35 *
At a glance
- Drugs Sonidegib (Primary) ; Bupropion; Warfarin
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Novartis
- 15 Aug 2016 Status changed from active, no longer recruiting to completed.
- 01 Aug 2016 Planned End Date changed from 1 Nov 2016 to 1 Sep 2016.
- 01 Aug 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Sep 2016.